Die Pentixapharm AG ist ein 2019 gegründetes biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Radiopharmazeutika fokussiert. Das IPO erfolgte im Oktober 2024.
COMPANY
INVESTOR TERMSHEET
LEI:
3912005VBOVXNDXEQZ36
SECTOR:
Gesundheit
SUB-SECTOR:
Pharma
NAME
Pentixapharm Holding
WKN
A40AEG
ISIN
DE000A40AEG0
TICKER
PTP
INDEX
EXCHANGE
Xetra
#BGFL-nes Pentixapharm Holding: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.
| 21.11.2024 | Pentixapharm Holding: Bislang unterschätzte Aktie |
| 01.10.2024 | Pentixapharm Holding: Seltene Kombination |
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
